TG Therapeutics Inc logo

TG Therapeutics Inc

NEW
STU:NKB2 (USA)   Ordinary Shares
€ 40 -5 (-11.11%) Aug 3
16.15
P/B:
12.13
Market Cap:
€ 6.13B ($ 7.06B)
Enterprise V:
€ 6.33B ($ 7.30B)
Volume:
300.00
Avg Vol (2M):
167.00
Trade In:

TG Therapeutics Inc Operating Data

TG Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

TG Therapeutics Inc (STU:NKB2) Operating Data Charts